References
- Chattopadhyay B. Newborns and gentamicin - how much and how often? J Antimicrob Chemother 2002; 49: 13–16.
- de Hoog M, Mouton JW, van den Anker JN. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 2005; 10: 185–194.
- Fanos V, Dall’Agnola A. Antibiotics in neonatal infections. A Review. Drugs 1999; 58 (3): 405–427.
- Fanos V, Cuzzolin L, Atzei A, Testa M. Antibiotics and antifungals in neonatal intensive care units: a review. J Chemother 2007; 19(1):5–20.
- Fanos V, Cataldi L. Antibiotic-induced nephrotoxicity in the newborn, Drug Safety 1999 ;20(3):245–67.
- de Hoog M, Mouton JW, Schoemaker RC, Verduin CM, van den Anker JN. Extended interval dosing of tobramycin in neonates: implication for therapeutic drug monitoring. Clin Pharmacol Ther 2002; 71: 349–358.
- Pons G, Treluyer JM, Dimet J et al. Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates. Ther Drug Monit 2002; 24 (1): 9–14.
- Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JPA. Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 2004; 114: 11–118.
- Miron D. Once daily dosing of gentamicin in infants and children. Pediatr Infect Dis J 2001; 20: 1169–1173.
- Uijtendaal EV, Rademaker CM, Schobben AF et al. Once-daily versus multiple-daily gentamicin in infants and children. Ther Drug Monit 2001; 23: 506–513.